<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Clin Transl Hepatol</journal-id><journal-id journal-id-type="iso-abbrev">J Clin Transl Hepatol</journal-id><journal-id journal-id-type="publisher-id">JCTH</journal-id><journal-title-group><journal-title>Journal of Clinical and Translational Hepatology</journal-title></journal-title-group><issn pub-type="ppub">2225-0719</issn><issn pub-type="epub">2310-8819</issn><publisher><publisher-name>XIA &#x00026; HE Publishing Inc.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">PMC9396312</article-id><article-id pub-id-type="publisher-id">JCTH.2020.00080</article-id><article-id pub-id-type="doi">10.14218/JCTH.2020.00080</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Hepatic Histoplasmosis: An Update</article-title><alt-title alt-title-type="running-head-verso">Sayeed M. <italic>et al</italic>: Hepatic histoplasmosis</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Sayeed</surname><given-names>Maimuna</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Benzamin</surname><given-names>Md</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="COR1" ref-type="corresp">*</xref><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8239-6541</contrib-id></contrib><contrib contrib-type="author"><name><surname>Nahar</surname><given-names>Luthfun</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Rana</surname><given-names>Masud</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Aishy</surname><given-names>Aisharza Sultana</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><aff id="aff1"><label>1</label>Department of Paediatric Gastroenterology &#x00026; Nutrition, Bangabandhu Shiekh Mujib Medical University (BSMMU), Dhaka, Bangladesh</aff><aff id="aff2"><label>2</label>Hazi Asmot Ali Medical Centre, Bhairab, Kishoregonj, Dhaka, Bangladesh</aff><aff id="aff3"><label>3</label>Jalalabad Ragib-Rabeya Medical College, Sylhet, Bangladesh</aff></contrib-group><author-notes><corresp id="COR1"><label>*</label><bold>Correspondence to:</bold> Md Benzamin, Department of Paediatric Gastroenterology &#x00026; Nutrition, Bangabandhu Shiekh Mujib Medical University (BSMMU), Dhaka, Bangladesh. ORCID: <ext-link xlink:href="https://orcid.org/0000-0002-8239-6541" ext-link-type="uri">https://orcid.org/0000-0002-8239-6541</ext-link>. Tel: +88-1719183948, E-mail: <email>drmd.benzamin@yahoo.com</email></corresp><fn fn-type="financial-disclosure"><p>None to declare.</p></fn><fn fn-type="COI-statement"><p>The authors have no conflict of interests related to this publication.</p></fn><fn fn-type="con"><p>Literature review (MS, MB, LN, MR, ASA), manuscript writing (MS, MB), histopathology and endoscopy picture collection, and manuscript editing (LN, MR, ASA).</p></fn></author-notes><pub-date pub-type="ppub"><day>28</day><month>8</month><year>2022</year></pub-date><pub-date pub-type="epub"><day>22</day><month>9</month><year>2021</year></pub-date><volume>10</volume><issue>4</issue><fpage>726</fpage><lpage>729</lpage><history><date date-type="received"><day>24</day><month>8</month><year>2020</year></date><date date-type="rev-recd"><day>8</day><month>11</month><year>2020</year></date><date date-type="accepted"><day>1</day><month>7</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; 2022 Authors.</copyright-statement><copyright-year>2022</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p><italic>Histoplasma capsulatum</italic> is the most common cause of endemic mycosis in developing countries. It is a self-limited and asymptomatic disease in immunocompetent individuals but remains a frequent cause of opportunistic infection in patients with compromised immune status. Liver involvement as a part of disseminated histoplasmosis is well known. However, liver infection as a primary manifestation of histoplasmosis without evidence of primary lung involvement is rare. In conclusion, clinicians should be aware of isolated histoplasmosis affecting the hepatobiliary system, and careful evaluation is warranted to confirm the diagnosis. Given the appropriate clinical context, histoplasmosis should be considered in both immunocompetent and immunocompromised patients, regardless of pulmonary symptoms, in non endemic as well as endemic areas.</p></abstract><kwd-group><kwd><italic>Histoplasma capsulatum</italic></kwd><kwd>Histoplasmosis</kwd><kwd>Hepatic manifestation</kwd><kwd>Mycosis</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Histoplasmosis is a systemic fungal disease that is caused by the dimorphic fungus <italic>Histoplasma capsulatum</italic>, which usually infects an individual by way of the respiratory tract. Cases comprise two distinct groups of conditions&#x02014;the subcutaneous and systemic mycoses. The fungal infection has recently emerged as an important opportunistic infection among immunocompromised patients living in endemic areas for this fungus, and are prone to develop more severe disease.<xref rid="JCTH-D-20-00080-b1" ref-type="bibr">1</xref></p></sec><sec id="s2"><title>Epidemiology</title><p>Histoplasmosis is distributed worldwide but endemic in the Americas, Africa, and Asia. The actual incidence of histoplasmosis is not known, as the majority of the studies done on this subject have been limited to regions affected by outbreaks of the disease. Globally, about half a million people get infected with <italic>Histoplasma</italic> infection every year. However, approximately 100,000 people develop disseminated histoplasmosis,<xref rid="JCTH-D-20-00080-b2" ref-type="bibr">2</xref> which is associated with high mortality rates (ranging between 30&#x02013;50% if treated and 100% if not).<xref rid="JCTH-D-20-00080-b3" ref-type="bibr">3</xref>&#x02013;<xref rid="JCTH-D-20-00080-b5" ref-type="bibr">5</xref> In North America, the area of highest endemicity is in the Mississippi and Ohio River Valleys of the USA. In these areas, the incidence of histoplasmosis reaches up to an estimated 6.1 cases per 100,000.<xref rid="JCTH-D-20-00080-b6" ref-type="bibr">6</xref>,<xref rid="JCTH-D-20-00080-b7" ref-type="bibr">7</xref> Through a 2011&#x02013;2014 surveillance of cases in the USA, state-specific annual incidence rates were found to range from 0 to 4.3/100,000 population.<xref rid="JCTH-D-20-00080-b8" ref-type="bibr">8</xref></p><p>A recent systematic literature review of both case volume and type of histoplasmosis in Southeast Asia, excluding the Indian sub-continent, found a total of 407 cases.<xref rid="JCTH-D-20-00080-b9" ref-type="bibr">9</xref> Most cases (255 (63%)) were disseminated histoplasmosis.<xref rid="JCTH-D-20-00080-b9" ref-type="bibr">9</xref> The highest burden of histoplasmosis was noted in Myanmar, Bali, and Surabaya in Indonesia, Ho ChiMinh City in Vietnam, southern Thailand, and north Luzon in the Philippines. In the East African region, a study from Northern Tanzania retrospectively identified 9 (0.9%) cases of probable histoplasmosis among 970 febrile in-patients.<xref rid="JCTH-D-20-00080-b10" ref-type="bibr">10</xref></p><p>In Bangladesh, all variants of fungal infections are tracked and some studies have documented their frequency. In a study of 3,435 patients attending a dermatology clinic, 601 (17.5%) were diagnosed with superficial fungus infections.<xref rid="JCTH-D-20-00080-b11" ref-type="bibr">11</xref> Deep mycoses are also an important evolving problem, as evidenced by reports of 16 cases of histoplasmosis with varying clinical manifestations.<xref rid="JCTH-D-20-00080-b12" ref-type="bibr">12</xref>,<xref rid="JCTH-D-20-00080-b13" ref-type="bibr">13</xref> Isolated hepatic histoplasmosis is an uncommon condition; liver involvement is commonly associated with disseminated histoplasmosis. <italic>H. capsulatum</italic> has been recovered from soil of the Gangetic plains.<xref rid="JCTH-D-20-00080-b14" ref-type="bibr">14</xref> When soil is disturbed by construction or excavation, the spores become airborne and are then inhaled.<xref rid="JCTH-D-20-00080-b15" ref-type="bibr">15</xref> Considering the likeness of geo-climatic conditions, it is possible that many more cases of histoplasmosis occur in Bangladesh than are currently documented.</p></sec><sec id="s3"><title>Pathogenesis</title><p>Upon inhalation of airborne spores, once they reach the alveoli, they convert to a yeast form, which is the tissue-invasive form. The current multiplying yeasts are then phagocytosed by alveolar macrophages, that are initially incapable of killing the fungus. The ingested yeasts multiply inside the macrophages and during the pre-immune phase of the illness, and they are then spread throughout the body via the lymphatics to organs rich in reticuloendothelial cells.<xref rid="JCTH-D-20-00080-b16" ref-type="bibr">16</xref> Hematogenous dissemination usually occurs before cellular immunity develops, during the first 2 weeks.<xref rid="JCTH-D-20-00080-b17" ref-type="bibr">17</xref> In an immunocompetent host, once sufficient cell-mediated immunity develops, the infection is eliminated by cytokines (e.g., interferon-&#x003b3; and interleukin-12) which aid macrophages in either killing the organism or halting their progression by forming a calcified granuloma.<xref rid="JCTH-D-20-00080-b18" ref-type="bibr">18</xref> In immunosuppressed patients, especially those with defective cell-mediated immunity, these defense mechanisms are impaired, causing reactivation of old foci or a progressive dissemination involving the extra-pulmonary tissues.<xref rid="JCTH-D-20-00080-b19" ref-type="bibr">19</xref> The typical incubation period is 7&#x02013;21 days.<xref rid="JCTH-D-20-00080-b15" ref-type="bibr">15</xref></p></sec><sec id="s4"><title>Predisposing factors</title><p>A variety of conditions can predispose to disseminated histoplasmosis, such as immunocompromised condition (i.e. acquired immune deficiency syndrome (AIDS)), taking of immunosuppressive medications (i.e. glucocorticoids, anti-rejection therapies in solid organ transplantation, or TNF-&#x003b1; inhibitor therapies), primary immunodeficiency, and extremes of age.<xref rid="JCTH-D-20-00080-b20" ref-type="bibr">20</xref>&#x02013;<xref rid="JCTH-D-20-00080-b22" ref-type="bibr">22</xref></p></sec><sec id="s5"><title>Clinical features</title><p>Histoplasmosis can present in various forms, including:</p><list list-type="bullet"><list-item><p>Asymptomatic primary infection</p></list-item><list-item><p>Acute pulmonary histoplasmosis</p></list-item><list-item><p>Sequelae: mediastinal granuloma, rheumatologic syndromes, pericarditis</p></list-item><list-item><p>Chronic pulmonary histoplasmosis</p></list-item><list-item><p>Disseminated histoplasmosis</p></list-item><list-item><p>Other: mediastinal fibrosis, broncholithiasis, central nervous system histoplasmosis, gastrointestinal histoplasmosis, hepatic histoplasmosis.<xref rid="JCTH-D-20-00080-b19" ref-type="bibr">19</xref>,<xref rid="JCTH-D-20-00080-b23" ref-type="bibr">23</xref></p></list-item></list><p>&#x02029;The most common symptoms of the disseminated forms are fever (89.1%), respiratory symptoms (38.1%), weight loss (37.4%), and various common signs, including splenomegaly (72%), hepatomegaly (68.1%) and lymphadenopathy (41.2%).<xref rid="JCTH-D-20-00080-b24" ref-type="bibr">24</xref> Initial infection occurs in the lung alveoli, and then is transformed by the reticuloendothelial system and spread to various organs, resulting in progressive disseminated histoplasmosis.<xref rid="JCTH-D-20-00080-b23" ref-type="bibr">23</xref></p></sec><sec id="s6"><title>Hepatic histoplasmosis</title><p>Hepatic histoplasmosis can occur both in children and adults, in immunocompetent and immunocompromised patients, and in endemic and nonendemic areas.<xref rid="JCTH-D-20-00080-b24" ref-type="bibr">24</xref> Hepatic involvement is frequent in disseminated histoplasmosis. The liver is reportedly involved in about 90% of patients with disseminated histoplasmosis.<xref rid="JCTH-D-20-00080-b25" ref-type="bibr">25</xref> However, liver histoplasmosis as a primary sign of histoplasmosis without lung involvement is uncommon. Patients with primary liver involvement usually present with nonspecific symptoms, such as fever, fatigue, nausea, vomiting, weight loss, and elevation of liver enzymes. They may present with stigmata of chronic liver disease, portal hypertension, ascites, and/or varices. These features may be due to chronic parenchymal liver disease resulting from histoplasma-induced liver injury. The full spectrum of hepatic manifestations of this disease is unknown but spans the range in the literature from mildly abnormal liver enzymes to severe icteric cholestasis with fever and pain.<xref rid="JCTH-D-20-00080-b24" ref-type="bibr">24</xref>&#x02013;<xref rid="JCTH-D-20-00080-b26" ref-type="bibr">26</xref></p><p><italic>H.capsulatum</italic> is an uncommon cause of granulomatous liver disease. There are few case reports on hepatic histoplasmosis with atypical presentations. Sartin <italic>et al</italic>.<xref rid="JCTH-D-20-00080-b27" ref-type="bibr">27</xref> from the Mayo Clinic (Rochester, MN, USA) found histoplasmosis comprised 4.5% (4 of 88) of cases of idiopathic granulomatous disease. Cholestasis due to <italic>H. capsulatum</italic> in the setting of primary liver manifestation has been rarely detected. Only a few case reports of liver biopsy-proven histoplasmosis have reported associated cholestasis.<xref rid="JCTH-D-20-00080-b25" ref-type="bibr">25</xref>,<xref rid="JCTH-D-20-00080-b28" ref-type="bibr">28</xref>&#x02013;<xref rid="JCTH-D-20-00080-b30" ref-type="bibr">30</xref></p><p>The typical clinical presentations are fever and jaundice in the setting of immunosuppression. Right upper quadrant pain might be confused with biliary colic in cases of cholestatic hepatitis secondary to disseminated histoplasmosis.<xref rid="JCTH-D-20-00080-b24" ref-type="bibr">24</xref> Clinically, these patients are usually symptomatic with elevated liver enzymes and pyrexia of unknown origin.<xref rid="JCTH-D-20-00080-b31" ref-type="bibr">31</xref> There is one case report in the publicly available literature that describes a patient with acute cholestatic granulomatous hepatitis with disseminated histoplasmosis.<xref rid="JCTH-D-20-00080-b24" ref-type="bibr">24</xref> Obstruction by peri-portal lymph nodes results in obstructive jaundice.<xref rid="JCTH-D-20-00080-b20" ref-type="bibr">20</xref> Two case reports by Park <italic>et al</italic>.<xref rid="JCTH-D-20-00080-b24" ref-type="bibr">24</xref> and Kothadia <italic>et al</italic>.<xref rid="JCTH-D-20-00080-b30" ref-type="bibr">30</xref> describe patients who underwent laparoscopic cholecystectomy for uncertain etiology shortly before being diagnosed with disseminated histoplasmosis. Nahar <italic>et al</italic>.<xref rid="JCTH-D-20-00080-b28" ref-type="bibr">28</xref> reported a patient with disseminated histoplasmosis that presented as chronic liver disease with portal hypertension.</p></sec><sec id="s7"><title>Diagnosis</title><p>Disseminated histoplasmosis can be diagnosed using various methods, like antigen detection, cultures, serology, or direct microscopy. Recovery of the organism from a biologic extra-pulmonary specimen is the gold standard.<xref rid="JCTH-D-20-00080-b16" ref-type="bibr">16</xref></p><p>Laboratory values are highly variable for this disease. Transaminase levels are usually above the upper limit of normal, and the elevated alkaline phosphatase level is often as high as &#x0003e;2,100 U/L. In addition, high total bilirubin is usually associated with a concomitant rise in direct bilirubin, and &#x003b3;-glutamyl transpeptidase (GGT) is significantly elevated as demonstrated by the case reported by Gill <italic>et al</italic>.<xref rid="JCTH-D-20-00080-b31" ref-type="bibr">31</xref> A liver biopsy is often obtained in conjunction with serum and urine antigen studies to establish the diagnosis.</p><p>The tissue response in histoplasmosis causes granulomas that are visible by histopathologic examinations. Grocott-Gomorimethenamine-silver nitrate and periodic acid-Schiff stains are useful for visualizing <italic>Histoplasma</italic> organisms in tissues. The early lesions in the tissue specimen contain a large number of macrophages and lymphocytes, with occasional epithelioid cells and multinucleated giant cells. Histological examination shows varying degrees of central caseation and occasionally calcification. Areas of caseous necrosis with a surrounding fibrous capsule which prevents the spread of the organism are characteristic. <italic>H. capsulatum</italic> may also be seen in tissues inside macrophages (<xref rid="JCTH-D-20-00080-f1" ref-type="fig">Fig. 1</xref>).<xref rid="JCTH-D-20-00080-b29" ref-type="bibr">29</xref> If features of portal hypertension are present, then esophagogastrodudenoscopy should be performed to identify and evaluate varices (<xref rid="JCTH-D-20-00080-f2" ref-type="fig">Fig. 2</xref>).<xref rid="JCTH-D-20-00080-b28" ref-type="bibr">28</xref></p><fig position="float" id="JCTH-D-20-00080-f1"><label>Fig. 1</label><caption><title>Histopathological examination.</title><p>(A, B) Representative staining samples. Arrows indicate <italic>H. capsulatum</italic>.</p></caption><graphic xlink:href="JCTH-10-726-g001" position="float"/></fig><fig position="float" id="JCTH-D-20-00080-f2"><label>Fig. 2</label><caption><title>Large esophageal varices in a child with disseminated histoplasmosis.</title></caption><graphic xlink:href="JCTH-10-726-g002" position="float"/></fig></sec><sec id="s8"><title>Treatment</title><p>Prompt diagnosis and initiation of antifungal therapy are crucial in immunocompromised, who otherwise have a fatality rate of 100% if left untreated,<xref rid="JCTH-D-20-00080-b8" ref-type="bibr">8</xref> The agents most commonly used for the treatment of histoplasmosis are amphotericin B and itraconazole. For moderately severe to severe disease, liposomal amphotericin B (3mg/kg/day) is suggested for 1&#x02013;2 weeks, followed by oral itraconazole (200mg thrice daily for 3 days and then 200mg twice daily for a total of at least 12 months). Liposomal formulation is preferred to deoxycholate, due to its superior side effect profile, better response rate, and survival benefit. Patients with mild-to-moderate disease can be treated with itraconazole.<xref rid="JCTH-D-20-00080-b30" ref-type="bibr">30</xref></p></sec><sec id="s9"><title>Monitoring</title><p>Antigen levels in urine can be used to monitor the response to treatment. Antigen levels usually decline by the end of 12 weeks, and more rapidly in serum than in urine. Most of the decline in antigen level was seen in the first 2 weeks of therapy.<xref rid="JCTH-D-20-00080-b32" ref-type="bibr">32</xref> An increase in antigen concentration indicates relapse or treatment failure, and further evaluation of the adequacy of treatment is needed.<xref rid="JCTH-D-20-00080-b22" ref-type="bibr">22</xref></p></sec><sec id="s10"><title>Conclusions</title><p>The liver is involved in about 90% of patients with disseminated histoplasmosis. Hepatic histoplasmosis can present as granulomatous hepatitis, as stigmata of chronic liver disease, portal hypertension, comprising ascites or varices, or with elevated liver enzymes. The most common hepatic finding seen on liver biopsy is portal lymphohistiocytic inflammation. Discrete hepatic granulomas are found in less than 20% cases of involved livers. There are limited case reports of disseminated histoplasmosis presenting as primary hepatic histoplasmosis. A high clinical suspicion is warranted in patients who present with stigmata of chronic liver disease and portal hypertension with no evidence of cirrhosis, especially if the person lives in or has visited an endemic area.<xref rid="JCTH-D-20-00080-b28" ref-type="bibr">28</xref></p></sec></body><back><ref-list><title>References</title><ref id="JCTH-D-20-00080-b1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cano</surname><given-names>MV</given-names></name><name><surname>Hajjeh</surname><given-names>RA</given-names></name></person-group><article-title>The epidemiology of histoplasmosis: a review</article-title><source>Semin Respir Infect</source><year>2001</year><volume>16</volume><issue>2</issue><fpage>109</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1053/srin.2001.24241</pub-id><pub-id pub-id-type="pmid">11521243</pub-id></element-citation></ref><ref id="JCTH-D-20-00080-b2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denning</surname><given-names>DW</given-names></name></person-group><article-title>Minimizing fungal disease deaths will allow the UNAIDS target of reducing annual AIDS deaths below 500 000 by 2020 to be realized</article-title><source>Philos Trans R Soc Lond B Biol Sci</source><year>2016</year><volume>371</volume><issue>1709</issue><fpage>20150468</fpage><pub-id pub-id-type="doi">10.1098/rstb.2015.0468</pub-id><pub-id pub-id-type="pmid">28080991</pub-id></element-citation></ref><ref id="JCTH-D-20-00080-b3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adenis</surname><given-names>A</given-names></name><name><surname>Nacher</surname><given-names>M</given-names></name><name><surname>Hanf</surname><given-names>M</given-names></name><name><surname>Vantilcke</surname><given-names>V</given-names></name><name><surname>Boukhari</surname><given-names>R</given-names></name><name><surname>Blachet</surname><given-names>D</given-names></name><etal/></person-group><article-title>HIV-associated histoplasmosis early mortality and incidence trends: from neglect to priority</article-title><source>PLoS Negl Trop Dis</source><year>2014</year><volume>8</volume><issue>8</issue><fpage>e3100</fpage><pub-id pub-id-type="doi">10.1371/journal.pntd.0003100</pub-id><pub-id pub-id-type="pmid">25144374</pub-id></element-citation></ref><ref id="JCTH-D-20-00080-b4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>GD</given-names></name><name><surname>Denning</surname><given-names>DW</given-names></name><name><surname>Gow</surname><given-names>NA</given-names></name><name><surname>Levitz</surname><given-names>SM</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>White</surname><given-names>TC</given-names></name></person-group><article-title>Hidden killers: human fungal infections</article-title><source>Sci Transl Med</source><year>2012</year><volume>4</volume><issue>165</issue><fpage>165rv13</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.3004404</pub-id></element-citation></ref><ref id="JCTH-D-20-00080-b5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almeida</surname><given-names>MA</given-names></name><name><surname>Almeida-Silva</surname><given-names>F</given-names></name><name><surname>Guimar&#x000e3;es</surname><given-names>AJ</given-names></name><name><surname>Almeida-Paes</surname><given-names>R</given-names></name><name><surname>Zancop&#x000e9;-Oliveira</surname><given-names>RM</given-names></name></person-group><article-title>The occurrence of histoplasmosis in Brazil: A systematic review</article-title><source>Int J Infect Dis</source><year>2019</year><volume>86</volume><fpage>147</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2019.07.009</pub-id><pub-id pub-id-type="pmid">31330326</pub-id></element-citation></ref><ref id="JCTH-D-20-00080-b6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manos</surname><given-names>NE</given-names></name><name><surname>Ferebee</surname><given-names>SH</given-names></name><name><surname>Kerschbaum</surname><given-names>WF</given-names></name></person-group><article-title>Geographic variation in the prevalence of histoplasmin sensitivity</article-title><source>Dis Chest</source><year>1956</year><volume>29</volume><issue>6</issue><fpage>649</fpage><lpage>668</lpage><pub-id pub-id-type="doi">10.1378/chest.29.6.649</pub-id><pub-id pub-id-type="pmid">13317782</pub-id></element-citation></ref><ref id="JCTH-D-20-00080-b7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baddley</surname><given-names>JW</given-names></name><name><surname>Winthrop</surname><given-names>KL</given-names></name><name><surname>Patkar</surname><given-names>NM</given-names></name><name><surname>Delzell</surname><given-names>E</given-names></name><name><surname>Beukelman</surname><given-names>T</given-names></name><name><surname>Xie</surname><given-names>F</given-names></name><etal/></person-group><article-title>Geographic distribution of endemic fungal infections among older persons, United States</article-title><source>Emerg Infect Dis</source><year>2011</year><volume>17</volume><issue>9</issue><fpage>1664</fpage><lpage>1669</lpage><pub-id pub-id-type="doi">10.3201/eid1709.101987</pub-id><pub-id pub-id-type="pmid">21888792</pub-id></element-citation></ref><ref id="JCTH-D-20-00080-b8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armstrong</surname><given-names>PA</given-names></name><name><surname>Jackson</surname><given-names>BR</given-names></name><name><surname>Haselow</surname><given-names>D</given-names></name><name><surname>Fields</surname><given-names>V</given-names></name><name><surname>Ireland</surname><given-names>M</given-names></name><name><surname>Austin</surname><given-names>C</given-names></name><etal/></person-group><article-title>Multistate epidemiology of histoplasmosis, United States, 2011-2014</article-title><source>Emerg Infect Dis</source><year>2018</year><volume>24</volume><issue>3</issue><fpage>425</fpage><lpage>431</lpage><pub-id pub-id-type="doi">10.3201/eid2403.171258</pub-id><pub-id pub-id-type="pmid">29460731</pub-id></element-citation></ref><ref id="JCTH-D-20-00080-b9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>J</given-names></name><name><surname>Setianingrum</surname><given-names>F</given-names></name><name><surname>Wahyuningsih</surname><given-names>R</given-names></name><name><surname>Denning</surname><given-names>DW</given-names></name></person-group><article-title>Mapping histoplasmosis in South East Asia - implications for diagnosis in AIDS</article-title><source>Emerg Microbes Infect</source><year>2019</year><volume>8</volume><issue>1</issue><fpage>1139</fpage><lpage>1145</lpage><pub-id pub-id-type="doi">10.1080/22221751.2019.1644539</pub-id><pub-id pub-id-type="pmid">31364950</pub-id></element-citation></ref><ref id="JCTH-D-20-00080-b10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lofgren</surname><given-names>SM</given-names></name><name><surname>Kirsch</surname><given-names>EJ</given-names></name><name><surname>Maro</surname><given-names>VP</given-names></name><name><surname>Morrissey</surname><given-names>AB</given-names></name><name><surname>Msuya</surname><given-names>LJ</given-names></name><name><surname>Kinabo</surname><given-names>GD</given-names></name><etal/></person-group><article-title>Histoplasmosis among hospitalized febrile patients in northern Tanzania</article-title><source>Trans R Soc Trop Med Hyg</source><year>2012</year><volume>106</volume><issue>8</issue><fpage>504</fpage><lpage>507</lpage><pub-id pub-id-type="doi">10.1016/j.trstmh.2012.05.009</pub-id><pub-id pub-id-type="pmid">22742942</pub-id></element-citation></ref><ref id="JCTH-D-20-00080-b11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rehman</surname><given-names>MH</given-names></name><name><surname>Hadiuzzaman</surname><given-names>Md</given-names></name><name><surname>Bhuiyan</surname><given-names>MKJ</given-names></name><name><surname>Islam</surname><given-names>N</given-names></name><name><surname>Ansari</surname><given-names>NP</given-names></name><name><surname>Mumu</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Prevalence of superficial fungal infections in the rural areas of Bangladesh</article-title><source>Iran Journal of Dermatology</source><year>2011</year><volume>14</volume><issue>3</issue><fpage>86</fpage><lpage>91</lpage></element-citation></ref><ref id="JCTH-D-20-00080-b12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parvin</surname><given-names>R</given-names></name><name><surname>Amin</surname><given-names>R</given-names></name><name><surname>Mahbub</surname><given-names>MS</given-names></name><name><surname>Hasnain</surname><given-names>M</given-names></name><name><surname>Arif</surname><given-names>KM</given-names></name><name><surname>Miah</surname><given-names>MT</given-names></name><etal/></person-group><article-title>Deep fungal infection-an emerging problem in Bangladesh</article-title><source>J Medicine</source><year>2010</year><volume>11</volume><issue>2</issue><fpage>170</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.3329/jom.v11i2.5466</pub-id></element-citation></ref><ref id="JCTH-D-20-00080-b13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahbub</surname><given-names>MS</given-names></name><name><surname>Ahasan</surname><given-names>HN</given-names></name><name><surname>Miah</surname><given-names>MT</given-names></name><name><surname>Alam</surname><given-names>MB</given-names></name><name><surname>Gupta</surname><given-names>RD</given-names></name><name><surname>Arif</surname><given-names>KM</given-names></name><etal/></person-group><article-title>Disseminated histoplasmosis</article-title><source>J Medicine</source><year>2010</year><volume>11</volume><issue>1</issue><fpage>70</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.3329/jom.v11i1.4278</pub-id></element-citation></ref><ref id="JCTH-D-20-00080-b14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antinori</surname><given-names>S</given-names></name></person-group><article-title>Histoplasma capsulatum: more widespread than previously thought</article-title><source>Am J Trop Med Hyg</source><year>2014</year><volume>90</volume><issue>6</issue><fpage>982</fpage><lpage>983</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.14-0175</pub-id><pub-id pub-id-type="pmid">24778192</pub-id></element-citation></ref><ref id="JCTH-D-20-00080-b15"><label>15</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Deepe</surname><given-names>GS</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Bennett</surname><given-names>JE</given-names></name><name><surname>Dolin</surname><given-names>R</given-names></name><name><surname>Blaser</surname><given-names>MJ</given-names></name></person-group><article-title>265 - Histoplasma capsulatum (Histoplasmosis)</article-title><source>Mandell, Douglas, and Bennett&#x02019;s principles and practice of infectious diseases (Eighth Edition)</source><year>2015</year><publisher-loc>Philadelphia</publisher-loc><publisher-name>Content Repository Only</publisher-name><fpage>2949</fpage><lpage>2962.e1</lpage></element-citation></ref><ref id="JCTH-D-20-00080-b16"><label>16</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Schlossberg</surname><given-names>D</given-names></name></person-group><source>Clinical infectious disease</source><year>2008</year><publisher-name>Cambridge University Press</publisher-name></element-citation></ref><ref id="JCTH-D-20-00080-b17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fojtasek</surname><given-names>MF</given-names></name><name><surname>Sherman</surname><given-names>MR</given-names></name><name><surname>Garringer</surname><given-names>T</given-names></name><name><surname>Blair</surname><given-names>R</given-names></name><name><surname>Wheat</surname><given-names>LJ</given-names></name><name><surname>Schnizlein-Bick</surname><given-names>CT</given-names></name></person-group><article-title>Local immunity in lung-associated lymph nodes in a murine model of pulmonary histoplasmosis</article-title><source>Infect Immun</source><year>1993</year><volume>61</volume><issue>11</issue><fpage>4607</fpage><lpage>4614</lpage><pub-id pub-id-type="doi">10.1128/iai.61.11.4607-4614.1993</pub-id><pub-id pub-id-type="pmid">8406857</pub-id></element-citation></ref><ref id="JCTH-D-20-00080-b18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>P</given-names></name><name><surname>Sieve</surname><given-names>MC</given-names></name><name><surname>Tewari</surname><given-names>RP</given-names></name><name><surname>Seder</surname><given-names>RA</given-names></name></person-group><article-title>Interleukin-12 modulates the protective immune response in SCID mice infected with Histoplasma capsulatum</article-title><source>Infect Immun</source><year>1997</year><volume>65</volume><issue>3</issue><fpage>936</fpage><lpage>942</lpage><pub-id pub-id-type="doi">10.1128/IAI.65.3.936-942.1997</pub-id><pub-id pub-id-type="pmid">9038300</pub-id></element-citation></ref><ref id="JCTH-D-20-00080-b19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wheat</surname><given-names>J</given-names></name></person-group><article-title>Histoplasmosis. Experience during outbreaks in Indianapolis and review of the literature</article-title><source>Medicine (Baltimore)</source><year>1997</year><volume>76</volume><issue>5</issue><fpage>339</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1097/00005792-199709000-00002</pub-id><pub-id pub-id-type="pmid">9352737</pub-id></element-citation></ref><ref id="JCTH-D-20-00080-b20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Assi</surname><given-names>MA</given-names></name><name><surname>Sandid</surname><given-names>MS</given-names></name><name><surname>Baddour</surname><given-names>LM</given-names></name><name><surname>Roberts</surname><given-names>GD</given-names></name><name><surname>Walker</surname><given-names>RC</given-names></name></person-group><article-title>Systemic histoplasmosis: a 15-year retrospective institutional review of 111 patients</article-title><source>Medicine (Baltimore)</source><year>2007</year><volume>86</volume><issue>3</issue><fpage>162</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1097/md.0b013e3180679130</pub-id><pub-id pub-id-type="pmid">17505255</pub-id></element-citation></ref><ref id="JCTH-D-20-00080-b21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wheat</surname><given-names>LJ</given-names></name><name><surname>Slama</surname><given-names>TG</given-names></name><name><surname>Norton</surname><given-names>JA</given-names></name><name><surname>Kohler</surname><given-names>RB</given-names></name><name><surname>Eitzen</surname><given-names>HE</given-names></name><name><surname>French</surname><given-names>ML</given-names></name><etal/></person-group><article-title>Risk factors for disseminated or fatal histoplasmosis. Analysis of a large urban outbreak</article-title><source>Ann Intern Med</source><year>1982</year><volume>96</volume><issue>2</issue><fpage>159</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-96-2-159</pub-id><pub-id pub-id-type="pmid">7059062</pub-id></element-citation></ref><ref id="JCTH-D-20-00080-b22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kauffman</surname><given-names>CA</given-names></name></person-group><article-title>Histoplasmosis: a clinical and laboratory update</article-title><source>Clin Microbiol Rev</source><year>2007</year><volume>20</volume><issue>1</issue><fpage>115</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1128/CMR.00027-06</pub-id><pub-id pub-id-type="pmid">17223625</pub-id></element-citation></ref><ref id="JCTH-D-20-00080-b23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wheat</surname><given-names>J</given-names></name><name><surname>Sarosi</surname><given-names>G</given-names></name><name><surname>McKinsey</surname><given-names>D</given-names></name><name><surname>Hamill</surname><given-names>R</given-names></name><name><surname>Bradsher</surname><given-names>R</given-names></name><name><surname>Johnson</surname><given-names>P</given-names></name><etal/></person-group><article-title>Practice guidelines for the management of patients with histoplasmosis. Infectious Diseases Society of America</article-title><source>Clin Infect Dis</source><year>2000</year><volume>30</volume><issue>4</issue><fpage>688</fpage><lpage>695</lpage><pub-id pub-id-type="doi">10.1086/313752</pub-id><pub-id pub-id-type="pmid">10770731</pub-id></element-citation></ref><ref id="JCTH-D-20-00080-b24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamps</surname><given-names>LW</given-names></name><name><surname>Molina</surname><given-names>CP</given-names></name><name><surname>West</surname><given-names>AB</given-names></name><name><surname>Haggitt</surname><given-names>RC</given-names></name><name><surname>Scott</surname><given-names>MA</given-names></name></person-group><article-title>The pathologic spectrum of gastrointestinal and hepatic histoplasmosis</article-title><source>Am J Clin Pathol</source><year>2000</year><volume>113</volume><issue>1</issue><fpage>64</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1309/X0Y2-P3GY-TWE8-DM02</pub-id><pub-id pub-id-type="pmid">10631859</pub-id></element-citation></ref><ref id="JCTH-D-20-00080-b25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodwin</surname><given-names>RA</given-names><suffix>Jr</suffix></name><name><surname>Shapiro</surname><given-names>JL</given-names></name><name><surname>Thurman</surname><given-names>GH</given-names></name><name><surname>Thurman</surname><given-names>SS</given-names></name><name><surname>Des Prez</surname><given-names>RM</given-names></name></person-group><article-title>Disseminated histoplasmosis: clinical and pathologic correlations</article-title><source>Medicine (Baltimore)</source><year>1980</year><volume>59</volume><issue>1</issue><fpage>1</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">7356773</pub-id></element-citation></ref><ref id="JCTH-D-20-00080-b26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rihana</surname><given-names>NA</given-names></name><name><surname>Kandula</surname><given-names>M</given-names></name><name><surname>Velez</surname><given-names>A</given-names></name><name><surname>Dahal</surname><given-names>K</given-names></name><name><surname>O&#x02019;Neill</surname><given-names>EB</given-names></name></person-group><article-title>Histoplasmosis presenting as granulomatous hepatitis: case report and review of the literature</article-title><source>Case Rep Med</source><year>2014</year><volume>2014</volume><fpage>879535</fpage><pub-id pub-id-type="doi">10.1155/2014/879535</pub-id><pub-id pub-id-type="pmid">25013413</pub-id></element-citation></ref><ref id="JCTH-D-20-00080-b27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname><given-names>A</given-names></name><name><surname>Abushamma</surname><given-names>S</given-names></name><name><surname>Esfeh</surname><given-names>JM</given-names></name></person-group><article-title>Extrapulmonary hepatic histoplasmosis presenting as chronic liver disease: A case report</article-title><source>American Journal of Gastroenterology</source><year>2018</year><volume>113</volume><fpage>S1275</fpage><lpage>S1276</lpage></element-citation></ref><ref id="JCTH-D-20-00080-b28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nahar</surname><given-names>L</given-names></name><name><surname>Benzamin</surname><given-names>M</given-names></name><name><surname>Sarkar</surname><given-names>N</given-names></name><name><surname>Roy</surname><given-names>U</given-names></name><name><surname>Nahar</surname><given-names>K</given-names></name><name><surname>Rukunuzzaman</surname><given-names>M</given-names></name><etal/></person-group><article-title>A 8- year Bangladeshi girl with disseminated histoplasmosis, presented as chronic liver disease with portal hypertension: a rare case report</article-title><source>BMC Pediatr</source><year>2020</year><volume>20</volume><issue>1</issue><fpage>284</fpage><pub-id pub-id-type="doi">10.1186/s12887-020-02189-4</pub-id><pub-id pub-id-type="pmid">32513141</pub-id></element-citation></ref><ref id="JCTH-D-20-00080-b29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wheat</surname><given-names>LJ</given-names></name></person-group><article-title>Laboratory diagnosis of histoplasmosis: update 2000</article-title><source>Semin Respir Infect</source><year>2001</year><volume>16</volume><issue>2</issue><fpage>131</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1053/srin.2001.24243</pub-id><pub-id pub-id-type="pmid">11521245</pub-id></element-citation></ref><ref id="JCTH-D-20-00080-b30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wheat</surname><given-names>LJ</given-names></name><name><surname>Freifeld</surname><given-names>AG</given-names></name><name><surname>Kleiman</surname><given-names>MB</given-names></name><name><surname>Baddley</surname><given-names>JW</given-names></name><name><surname>McKinsey</surname><given-names>DS</given-names></name><name><surname>Loyd</surname><given-names>JE</given-names></name><etal/></person-group><article-title>Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America</article-title><source>Clin Infect Dis</source><year>2007</year><volume>45</volume><issue>7</issue><fpage>807</fpage><lpage>825</lpage><pub-id pub-id-type="doi">10.1086/521259</pub-id><pub-id pub-id-type="pmid">17806045</pub-id></element-citation></ref><ref id="JCTH-D-20-00080-b31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>D</given-names></name><name><surname>Dean</surname><given-names>R</given-names></name><name><surname>Virk</surname><given-names>J</given-names></name><name><surname>Lyons</surname><given-names>M</given-names></name><name><surname>Hess</surname><given-names>M</given-names></name></person-group><article-title>Unusual presentation of disseminated histoplasmosis</article-title><source>Am J Emerg Med</source><year>2017</year><volume>35</volume><issue>4</issue><fpage>668.e3</fpage><lpage>668.e4</lpage><pub-id pub-id-type="doi">10.1016/j.ajem.2016.11.013</pub-id></element-citation></ref><ref id="JCTH-D-20-00080-b32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hage</surname><given-names>CA</given-names></name><name><surname>Kirsch</surname><given-names>EJ</given-names></name><name><surname>Stump</surname><given-names>TE</given-names></name><name><surname>Kauffman</surname><given-names>CA</given-names></name><name><surname>Goldman</surname><given-names>M</given-names></name><name><surname>Connolly</surname><given-names>P</given-names></name><etal/></person-group><article-title>Histoplasma antigen clearance during treatment of histoplasmosis in patients with AIDS determined by a quantitative antigen enzyme immunoassay</article-title><source>Clin Vaccine Immunol</source><year>2011</year><volume>18</volume><issue>4</issue><fpage>661</fpage><lpage>666</lpage><pub-id pub-id-type="doi">10.1128/CVI.00389-10</pub-id><pub-id pub-id-type="pmid">21307278</pub-id></element-citation></ref></ref-list><glossary><title>Abbreviations</title><def-list><def-item><term>AIDS</term><def><p>acquired immune deficiency syndrome</p></def></def-item><def-item><term>GGT</term><def><p>&#x003b3;-glutamyl transferase</p></def></def-item></def-list></glossary></back></article>
